A case of early thrombosis following a percutaneous tricuspid valve in valve implantation managed by thrombolysis
- PMID: 35524711
- DOI: 10.1111/echo.15362
A case of early thrombosis following a percutaneous tricuspid valve in valve implantation managed by thrombolysis
Abstract
Bioprosthetic valve thrombosis (BPVT) is a growing recognized entity, especially with the increasing use of the valve in vale procedures and the advent of new detection technologies (e.g., 4D CT and 4D echocardiography). The incidence of BPVT is higher in transcatheter valves than surgically implanted bioprosthetic valves. However, the best thromboprophylaxis regimen and optimal management strategy in the acute context remain unknown. This paper presents a case of early thrombosis following the percutaneous tricuspid valve in vale procedure that was successfully managed with thrombolysis.
Keywords: bioprosthetic valve thrombosis; fibrinolysis; percutaneous valve in valve procedure; transesophageal echocardiography.
© 2022 Wiley Periodicals LLC.
Similar articles
-
Outcomes of Warfarin Therapy for Bioprosthetic Valve Thrombosis of Surgically Implanted Valves: A Prospective Study.JACC Cardiovasc Interv. 2017 Feb 27;10(4):379-387. doi: 10.1016/j.jcin.2016.11.027. JACC Cardiovasc Interv. 2017. PMID: 28231905
-
Gradient changes in bioprosthetic valve thrombosis: duration of anticoagulation and strategies to improve detection.Open Heart. 2021 May;8(1):e001608. doi: 10.1136/openhrt-2021-001608. Open Heart. 2021. PMID: 34031215 Free PMC article.
-
Subclinical bioprosthetic aortic valve thrombosis: clinical and translational implications.Curr Opin Cardiol. 2017 Mar;32(2):137-146. doi: 10.1097/HCO.0000000000000373. Curr Opin Cardiol. 2017. PMID: 28030440 Review.
-
Early Prosthetic Valve Dysfunction Due to Bioprosthetic Valve Thrombosis: The Role of Echocardiography.JACC Cardiovasc Imaging. 2018 Jul;11(7):951-958. doi: 10.1016/j.jcmg.2017.06.022. Epub 2017 Oct 18. JACC Cardiovasc Imaging. 2018. PMID: 29055629
-
The Transcatheter Tricuspid Valve-in-Valve Technique in Degenerated Bioprostheses Without Fluoroscopic Radiopaque Landmarks.Curr Probl Cardiol. 2022 Nov;47(11):101081. doi: 10.1016/j.cpcardiol.2021.101081. Epub 2021 Dec 11. Curr Probl Cardiol. 2022. PMID: 34902393 Review.
References
REFERENCES
-
- Egbe AC, Pislaru SV, Pellikka PA, et al. Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol. 2015;66:2285-2294
-
- Abdel-Wahab M, Matheus S, Azeem L, et al. Clinical valve thrombosis after transcatheter aortic valve-in-valve implantation. Circ Cardiovasc Interv. 2018;11(11):e006730.
-
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72-e22.
-
- Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015-2024.
-
- Alavi SH, Groves EM, Kheradvar A. The effects of transcatheter valve crimping on pericardial leaflets. Ann Thorac Surg. 2014;97:1260-1266.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical